Jose E. Rivera, EVP, General Counsel at Intellia Therapeutics, Inc. (NTLA), sold 108,563 shares at $63.31 ($6.9M) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $6.9M NTLA by EVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.31 | 10,476 | $663K | 9.5% |
| 2 | $63.31 | 10,476 | $663K | 9.5% |
| 3 | $63.34 | 6,617 | $419K | 6.0% |
| 4 | $63.34 | 6,617 | $419K | 6.0% |
| 5 | $63.44 | 2,326 | $148K | 2.1% |
| 6 | $63.44 | 2,326 |
| $148K |
| 2.1% |
| 7 | $64.11 | 15,594 | $1000K | 14.4% |
| 8 | $64.11 | 15,594 | $1000K | 14.4% |
| 9 | $64.16 | 8,366 | $537K | 7.7% |
| 10 | $64.16 | 8,366 | $537K | 7.7% |
| 11 | $64.18 | 2,386 | $153K | 2.2% |
| 12 | $64.18 | 2,386 | $153K | 2.2% |
| 13 | $65.01 | 5,312 | $345K | 5.0% |
| 14 | $65.01 | 5,312 | $345K | 5.0% |
| 15 | $65.05 | 2,827 | $184K | 2.6% |
| 16 | $65.05 | 2,827 | $184K | 2.6% |
| 17 | $65.07 | 755 | $49K | 0.7% |
| Total | $63.99 avg | 108,563 | $6.9M | 100% |
| Filing → |
| NTLA | SELL | 2021-01-05 | $232K | — | Filing → |
| NTLA | SELL | 2020-12-03 | $247K | — | Filing → |
| NTLA | SELL | 2020-11-18 | $353K | — | Filing → |